What if technology redefined patient care rather than merely improving it? The patient journey is being reshaped in ways we couldn’t have predicted a decade ago. From virtual consultations to remote ...

Even with significant educational efforts, heart disease remains the leading cause of death in the US and worldwide—for both men and women. While statins are the standard of care, Esperion ...

Epic Systems and several healthcare providers have sued Health Gorilla and other companies, alleging they exploited ...

Omada, a virtual healthcare provider, announced Tuesday that it is expanding its GLP-1 companion solution to include musculoskeletal exercise programming and member-level reporting for employers, ...

AI rivals Anthropic and OpenAI are both expanding their large language models into healthcare. Anthropic is blending its enterprise and consumer tools in a single platform, while OpenAI is separating ...

Over the last 15 years serving the medical transcription industry, transcription technology has made a major impact on health care services. And the data agrees. By 2030 the medical transcription ...

Sanofi is walking away from a deal to license an experimental Maze Therapeutics drug for a rare enzyme deficiency after the Federal Trade Commission challenged the transaction as anti-competitive. The ...

Private equity activity in the global healthcare sector set a new record last year with an estimated $191 billion in deal value, according to new data from Bain & Company. Healthcare remains one of PE ...

Fullscript has partnered with wearable device company ŌURA to bring its biometric insights into Fullscript’s clinical workflow, the companies announced on Monday during the J.P. Morgan Healthcare ...

A quarter of Medicare spending occurs during the final year of a patient’s life. Billions of those dollars go toward care that is misaligned or unwanted, which is often due to a lack of planning for ...

Pharmaceutical companies need to spend money in order to make money, and the looming loss of patent exclusivity for numerous products has these companies out in force striking business deals to fill ...

The obesity rate has stopped increasing in the U.S., due in part to the growing use of GLP-1s — with one in eight Americans having taken one last year. While it’s certainly good news that the obesity ...